Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2810137 | 0.72 | CYP1A1 (0.34) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL16566706 | 0.72 | CYP1A1 (0.34) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL2806688 | 0.72 | PTPN1 (0.35) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL211753 | 0.71 | CYP1A1 (0.46) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL2811361 | 0.71 | CYP1A1 (0.37) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL2814698 | 0.70 | CYP1A1 (0.33) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL2810865 | 0.67 | HDAC8 (0.32) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL2888713 | 0.67 | CYP1A1 (0.31) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL28522318 | 0.67 | PDE2A (0.31) | CYP1A1CYP1B1HDAC8 | |
| SCHEMBL29029260 | 0.67 | CYP1A1 (0.31) | CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2202221-A1 | ACETYLENE COMPOUND | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | NAT1, KATNA1, KAT2B | CYP1A1 107/4885CYP1B1 134/4885HDAC8 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.